| 1 |
Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation
Wang JC, Liu YC, Chen YM, Wang AP, Wei Q, Liu DM, Zhang GP
Applied Microbiology and Biotechnology, 104(9), 3847, 2020 |
| 2 |
Identification of three PPV1 VP2 protein-specific B cell linear epitopes using monoclonal antibodies against baculovirus-expressed recombinant VP2 protein
Sun JH, Huang LP, Wei YW, Wang YP, Chen DJ, Du WJ, Wu HL, Feng L, Liu CM
Applied Microbiology and Biotechnology, 99(21), 9025, 2015 |
| 3 |
Porcine parvovirus infection induces apoptosis in PK-15 cells through activation of p53 and mitochondria-mediated pathway
Zhang HL, Huang Y, Du Q, Luo XM, Zhang L, Zhao XM, Tong DW
Biochemical and Biophysical Research Communications, 456(2), 649, 2015 |
| 4 |
A recombinant pseudorabies virus co-expressing capsid proteins precursor P1-2A of FMDV and VP2 protein of porcine parvovirus: a trivalent vaccine candidate
Hong Q, Qian P, Li XM, Yu XL, Chen HC
Biotechnology Letters, 29(11), 1677, 2007 |
